Medline Inc. Class A Common Stock (NASDAQ:MDLN) — Stock Price
Medline Inc. Class A Common Stock (NASDAQ:MDLN) is currently trading at $33.81 USD, down 4.03% today. Over the past 52 weeks, shares have ranged between $33.19 and $62.00. This page tracks Medline Inc. Class A Common Stock's live share price on the NASDAQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Medline Inc. Class A Common Stock (MDLN) market capitalisation.
Medline Inc. Class A Common Stock (MDLN) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Medline Inc. Class A Common Stock's daily closing share price and trading volume on the NASDAQ exchange over the past year, giving a clear view of recent price momentum and liquidity.
Medline Inc. Class A Common Stock Income Statement — Revenue, Profit & Earnings by Year
Medline Inc. Class A Common Stock's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Revenue | $28.43 Billion | $25.51 Billion | $23.23 Billion | $21.45 Billion |
| Cost of Revenue | $20.91 Billion | $19.22 Billion | $18.01 Billion | $16.89 Billion |
| Gross Profit | $7.52 Billion | $6.29 Billion | $5.22 Billion | $4.56 Billion |
| Research & Development | — | $67.00 Million | $60.00 Million | $58.00 Million |
| SG&A | $4.52 Billion | — | — | — |
| Total Operating Expenses | $5.31 Billion | $4.07 Billion | $3.78 Billion | $3.69 Billion |
| Operating Income | $2.21 Billion | $2.23 Billion | $1.44 Billion | $870.00 Million |
| EBITDA | $2.92 Billion | $3.53 Billion | $2.59 Billion | $1.85 Billion |
| EBIT | $2.21 Billion | $2.56 Billion | $1.64 Billion | $921.00 Million |
| Interest Expense | $812.00 Million | $1.31 Billion | $1.38 Billion | $911.00 Million |
| Income Before Tax | $1.25 Billion | $1.25 Billion | $264.00 Million | $10.00 Million |
| Income Tax Expense | $91.00 Million | $46.00 Million | $30.00 Million | $35.00 Million |
| Net Income | $1.16 Billion | $1.20 Billion | $234.00 Million | $-25.00 Million |
Medline Inc. Class A Common Stock Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Medline Inc. Class A Common Stock's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Total Assets | $38.48 Billion | $35.98 Billion | $36.12 Billion |
| Total Current Assets | $10.68 Billion | $8.27 Billion | $8.81 Billion |
| Cash & Equivalents | — | — | — |
| Short-term Investments | — | — | — |
| Net Receivables | $3.53 Billion | $3.22 Billion | $2.96 Billion |
| Inventory | $4.77 Billion | $4.46 Billion | $3.81 Billion |
| Property, Plant & Equipment | — | — | — |
| Goodwill | $8.08 Billion | $8.06 Billion | $7.53 Billion |
| Total Liabilities | $19.20 Billion | $19.45 Billion | $19.14 Billion |
| Total Current Liabilities | $2.49 Billion | $2.44 Billion | $2.13 Billion |
| Long-term Debt | $12.48 Billion | — | — |
| Net Debt | $10.62 Billion | $16.65 Billion | $15.24 Billion |
| Total Stockholder Equity | $10.74 Billion | $16.52 Billion | $16.98 Billion |
| Retained Earnings | $-7.00 Million | $0.00 | — |
Medline Inc. Class A Common Stock Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Medline Inc. Class A Common Stock generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Cash Flow | $1.74 Billion | $1.77 Billion | $1.69 Billion | $187.00 Million |
| Capital Expenditures | $447.00 Million | $364.00 Million | $285.00 Million | $254.00 Million |
| Free Cash Flow | $1.74 Billion | $1.41 Billion | $1.40 Billion | $-67.00 Million |
| Investing Cash Flow | $-474.00 Million | $-1.49 Billion | $-312.00 Million | $-264.00 Million |
| Financing Cash Flow | $399.00 Million | $-1.61 Billion | $-191.00 Million | $-84.00 Million |
| Dividends Paid | $518.00 Million | — | — | — |
| Stock-Based Compensation | $76.00 Million | — | — | — |
| Depreciation | $704.00 Million | $977.00 Million | $951.00 Million | $933.00 Million |
| Change in Cash | $1.69 Billion | $-1.33 Billion | $1.58 Billion | — |
Medline Inc. Class A Common Stock Earnings History — EPS Actual vs. Analyst Estimates
Track Medline Inc. Class A Common Stock's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 13, 2026 | 0.33 | 0.29 | +13.79% |
| Feb 25, 2026 | 0.38 | 0.24 | +58.33% |
| Dec 03, 2025 | 0.31 | 0.00 | — |